Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE

IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Standard Dose
100MG/5ML;15MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE is listed in Drugs@FDA under application 076478 (ANDA).

Marketing status: Discontinued Active ingredient IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - 100MG/5ML;15MG/5ML Sponsor PERRIGO Submission history Latest submission status date: 2012-03-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE is listed in Drugs@FDA under application 076478 (ANDA). Marketing status: Discontinued Active ingredient IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - 100MG/5ML;15MG/5ML Sponsor PERRIGO Submission history Latest submission status date: 2012-03-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE (IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline